Physician profile
Ellen De Moll
NPI 1518349877
$102,550.70
in general payments reported to CMS, 2019-2025
25 companies · $68K in 2025
The $68K reported for 2025 was more than what 97% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $228 · 2021: $695 · 2022: $756 · 2023: $2,390 · 2024: $30K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $66K · Consulting Fee: $16K · Food and Beverage: $9,961 · Travel and Lodging: $8,486 · Education: $380 · Honoraria: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $65,953.00 |
| Consulting Fee | $15,832.50 |
| Food and Beverage | $9,960.76 |
| Travel and Lodging | $8,485.89 |
| Education | $379.96 |
| Honoraria | $260.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $50,890.68 | 2023-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $30,967.91 | 2022-2025 | Nemluvio, Aklief |
| Sun Pharmaceutical Industries INC. | $7,936.00 | 2021-2025 | |
| Incyte Corporation | $2,802.64 | 2022-2025 | Opzelura |
| Takeda Pharmaceuticals U.S.A., INC. | $2,765.00 | 2025 | |
| Abbvie INC. | $1,449.55 | 2020-2025 | Rinvoq, Skyrizi |
| Regeneron Healthcare Solutions, INC. | $1,197.80 | 2020-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $1,127.78 | 2024-2025 | Tremfya, Simponi Aria |
| Pfizer INC. | $969.48 | 2020-2025 | |
| Lilly USA, LLC | $696.08 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Leo Pharma INC. | $339.13 | 2025 | Adbry, Anzupgo, Spevigo |
| Genzyme Corporation | $312.32 | 2020-2025 | |
| Dermavant Sciences, INC. | $298.39 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $143.35 | 2023-2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $138.48 | 2023 | Sotyktu |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $133.77 | 2024-2025 | |
| Novo Nordisk INC | $125.00 | 2025 | Wegovy |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $70.63 | 2020-2024 | Duobrii, Siliq |
| Organon LLC | $57.15 | 2025 | Vtama, Nexplanon |
| Merck Sharp & Dohme LLC | $28.54 | 2024 | Keytruda |
| Botanix Sb INC | $27.34 | 2025 | Sofdra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.20 | 2023 | Spevigo |
| Journey Medical Corporation | $18.78 | 2023 | |
| Almirall LLC | $18.40 | 2025 | Klisyri |
| Amgen INC. | $15.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen De Moll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.